Koutif Therapeutics

About:

Koutif Therapeutics is advancing discoveries from researchers at the University of Pittsburgh.

Website: https://koutiftherapeutics.com/

Description:

Koutif Therapeutics is advancing discoveries from researchers at the University of Pittsburgh. Their academic founders are developing an inhibitor of E3 ligase Fbxo3, which is implicated in the pathogenesis of inflammatory conditions such as neuropathic pain, bronchiolitis obliterans syndrome, irritable bowel disease, chronic obstructive pulmonary disease, rheumatoid arthritis, and acute lung injury.

Total Funding Amount:

$600000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cleveland, Ohio, United States

Founded Date:

2017-01-01

Contact Email:

MGuerard(AT)koutiftherapeutic.com

Founders:

Beibei Bill Chen, Rama Mallampalli

Number of Employees:

11-50

Last Funding Date:

2017-10-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai